PDT Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
PDT Partners's DGX Position: Q4 2020 in Review
PDT Partners sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 5,106 shares — an estimated $585K sold.
PDT Partners first reported a position in DGX in Q2 2013 and held it in 15 quarters. The position peaked at $10.1M in Q3 2016. 812 funds tracked by Wall St. Rank hold DGX as of Q4 2020.
- PDT Partners reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
- PDT Partners sold 5,106 Quest Diagnostics shares in Q4 2020, an estimated $585K.
- PDT Partners first reported a position in Quest Diagnostics in Q2 2013 and held it in 15 quarters.
- PDT Partners's Quest Diagnostics position peaked at $10.1M in Q3 2016.
- 812 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.
Based on PDT Partners's 13F filing for Q4 2020, filed 16 Feb 2021.